Inequalities in access to renal cancer drugs
Fricker, J.
European Journal of Cancer 43(8): 1226
2007
ISSN/ISBN: 0959-8049 PMID: 17632887 Document Number: 605879
Document emailed within 1 workday
Related Documents
Mileshkin, L.; Sullivan, D. 2011: Access to expensive anti-cancer drugs Journal of Law and Medicine 19(2): 232-243Giuliano, M.; Vella, S. 2007: Inequalities in health: access to treatment for HIV/AIDS Annali Dell'istituto Superiore di Sanita 43(4): 313-316
Marti, C.; Wolff, H. 2006: Social inequalities and access to health care: consequences of the revision of the Swiss insurance law (art 64A) Revue Medicale Suisse 2(85): 2503-2507
Terlikbayeva, A.; Zhussupov, B.; Primbetova, S.; Gilbert, L.; Atabekov, N.; Giyasova, G.; Ruziev, M.; Soliev, A.; Saliev, D.; El-Bassel, N. 2013: Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care Drug and Alcohol Dependence 132(Suppl 1): S61-S64
Ramos, A.ôn.C.V.; Alves, L.S.; Berra, T.ís.Z.; Popolin, M.P.; Arcoverde, M.A.M.; Campoy, L.T.; Martoreli, J.é F.; Lapão, L.ís.V.; Palha, P.F.; Arcêncio, R.A. 2018: Family Health Strategy, private health care, and inequalities in access to mammography in BrazilEstrategia de Salud Familiar, salud suplementaria y desigualdad en el acceso a la mamografía en Brasil Revista Panamericana de Salud Publica 42: E166
Martínez-Mesa, J.; Werutsky, G.; Campani, R.B.; Wehrmeister, F.C.és.; Barrios, C.H. 2013: Inequalities in Pap smear screening for cervical cancer in Brazil Preventive Medicine 57(4): 366-371
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Gulland, A. 2013: Access to HIV drugs should be widened, says WHO BMJ 347: f4172
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Stern, R.; Beresford, B.; Kimani, D. 2002: Access to essential drugs Developing World Bioethics 2(2): 99-103
Kalland, T. 2005: Antibody-based cancer drugs: developing antibody therapeutic approaches to deliver individualized cancer drugs Idrugs: the Investigational Drugs Journal 8(5): 364-365
Gakidou, E.; Nordhagen, S.; Obermeyer, Z. 2008: Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities PLoS medicine 5(6): e132
Oliver, R.T. 2000: Management of women with early breast cancer. New strategies are needed to address inequalities Bmj 321(7273): 1409
Nightingale, S.L.; Kimbrough, C.A.; Rheinstein, P.H. 1994: Access to investigational drugs for treatment purposes American Family Physician 50(4): 845-847
Pugliese, F.; Ciabattoni, G. 1984: The role of prostaglandins in the control of renal function: renal effects of nonsteroidal anti-inflammatory drugs Clinical and Experimental Rheumatology 2(4): 345-352
Khachanov, R.M. 1971: The dynamics of partial renal function in renal tuberculosis during treatment with single daily doses of antitubercular drugs Problemy Tuberkuleza 49(2): 42-45
Loff, B. 2002: No agreement reached in talks on access to cheap drugs Lancet 360(9349): 1951
Loff, B. 2002: No agreement reached in talks on access to cheap drugs Lancet 360(9349): 1951
Goemaere, E.; Kaninda, A-Valerie.; Ciaffi, L.; Mulemba, M.; t Hoen, E.; Pécoul, B. 2002: Do patents prevent access to drugs for HIV in developing countries? JAMA 287(7): 841
Roach, J.O. 2000: VSO launches campaign to increase access to AIDS drugs Bmj 321(7268): 1038